Qure.ai
PrivateLast Round
Grant
Jan 21, 2026
Est. Valuation
$145.17M
Total Funding Raised
$117.49M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Qure.ai is a health technology company that develops AI-powered radiology interpretation solutions to automate the analysis of medical images such as X-rays, CT scans, and MRIs for faster and more accurate disease diagnosis.
Sector
Healthcare & Life Sciences
Verticals
Medical Imaging, Medical AI, Healthcare Analytics, Computer Vision
Business Model
B2B
Customer Profile
Subscription SaaS, Usage-Based SaaS, Government Contracts
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Qure.ai Comparables
Compare Qure.ai with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Harrison.ai | 87% | |
| Aidoc | 84% | |
| Infervision | 84% |
Qure.ai Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jan 21, 2026 | ||||
| IPO | May 20, 2025 | ||||
| Series D | Sep 24, 2024 | ||||
| Series C | Mar 28, 2022 | ||||
| Grant | Feb 7, 2022 | ||||
VC Round | Feb 27, 2020 |
Key People
Founding team and executive leadership
Qure.ai Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Fractal Analytics | Series C, VC Round |
| Merck Global Health Innovation Fund | Series D |
| MassMutual Ventures Southeast Asia | Series C, VC Round |
| NHS Cancer Programme | Grant |
| Peak XV Partners | VC Round |
| SBRI Healthcare | Grant |
| 360 ONE Asset | Series D |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 29, 2026
Technology has impacted over 22 million patients in 90+ countries.
- Jun 29, 2026
Received 13 FDA clearances and 62 CE markings.
Recent news
Latest coverage and updates
- recognized_asSep 18, 2026
Qure recognized as Class IIb CE certification under the EU Medical Device Regulation on Sep 18th '26.
- hiresAug 26, 2026
Qure hired Mihir Bhanushali as Executive Vice President, Global Health on Aug 26th '26.
- hiresJul 11, 2026
Qure hired Malika as Chief Marketing Officer on Jul 11th '26.
- expands_offices_inJul 10, 2026
Qure expands offices in United States, Northern America, Americas.
- promotesJul 10, 2026
Qure promoted Amy Casey to Executive Vice President of Sales for North America on Jul 10th '26.
Qure.ai Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Qure.ai's valuation, stock price, and market status.
Is Qure.ai a public or private company?
Qure.ai is a private company.
What is the current stock price of Qure.ai?
Qure.ai is a private company with no public stock price. No recent secondary market data is available.
How much is Qure.ai worth (valuation)?
Qure.ai's valuation is estimated at $145.2M based on funding round data.
Can I buy Qure.ai stock?
Qure.ai shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Qure.ai's last funding round?
Qure.ai's most recent funding round was IPO on March 28, 2022.
Who are the main investors in Qure.ai?
Key investors in Qure.ai include 360 ONE Asset, Novo Holdings, 360 ONE Wealth, HealthQuad, 360 ONE Asset Management.
Will Qure.ai IPO soon?
No public IPO plans have been announced for Qure.ai.
How can I track Qure.ai secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Qure.ai's secondary market activity and sign up for updates.